login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
TARSUS PHARMACEUTICALS INC (TARS) Stock News
USA
- NASDAQ:TARS -
US87650L1035
-
Common Stock
50.6
USD
+1.01 (+2.04%)
Last: 9/16/2025, 4:45:39 PM
50.5
USD
-0.1 (-0.2%)
After Hours:
9/16/2025, 4:45:39 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TARS Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Participate in Upcoming Investor Conferences
20 days ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Participate in Upcoming Investor Conferences
22 days ago - By: MarketBeat
- Mentions:
BSX
ARQT
3 Biotech Catalysts Present Major Opportunity
a month ago - By: Benzinga
- Mentions:
PINC
EFXT
Top 2 Health Care Stocks That May Fall Off A Cliff In August
a month ago - By: Zacks Investment Research
- Mentions:
BFRI
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
a month ago - By: Tarsus Pharmaceuticals, Inc
Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
a month ago - By: Benzinga
- Mentions:
OEC
VTLE
DIN
INSE
...
Earnings Scheduled For August 6, 2025
a month ago - By: Tarsus Pharmaceuticals, Inc
Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
2 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
2 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
4 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Participate in Upcoming Investor Conferences
4 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Participate in Upcoming Investor Conferences
4 months ago - By: Zacks Investment Research
Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
4 months ago - By: Yahoo Finance
- Mentions:
UAL
COIN
DAL
AAL
...
United Airlines Holdings, Inc. (UAL): Among Billionaire Ken Griffin’s Midcap Stock Picks with Huge Upside Potential
4 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Participate in Upcoming Investor Conferences
4 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Participate in Upcoming Investor Conferences
5 months ago - By: Zacks Investment Research
- Mentions:
COR
HCA
ACRV
HCA Healthcare to Report Q1 Earnings: Key Estimates to Note
4 months ago - By: Yahoo Finance
- Mentions:
ZLAB
BX
GS
MTRX
...
Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts
4 months ago - By: Yahoo Finance
- Mentions:
GOGO
BX
GS
MTRX
...
Gogo Inc. (GOGO): Among the Best Breakout Stocks to Buy According to Analysts
4 months ago - By: Yahoo Finance
- Mentions:
ENTA
BX
GS
CCS
...
Enanta Pharmaceuticals, Inc. (ENTA): The Best Breakout Stock to Buy According to Analysts
4 months ago - By: Yahoo Finance
- Mentions:
ELAN
CEG
VST
UNP
...
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal
4 months ago - By: Elanco Animal Health
- Mentions:
ELAN
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown
5 months ago - By: Zacks Investment Research
- Mentions:
VNDA
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
5 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements
5 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements
5 months ago - By: Zacks Investment Research
- Mentions:
CI
COR
BNTC
Will Declining Medical Customers Affect Cigna's Q1 Earnings?
5 months ago - By: Zacks Investment Research
Wall Street Analysts See a 31.89% Upside in Tarsus Pharmaceuticals (TARS): Can the Stock Really Move This High?
5 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
5 months ago - By: Tarsus Pharmaceuticals, Inc
Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
5 months ago - By: Zacks Investment Research
- Mentions:
UHS
COR
ACRV
Universal Health to Report Q1 Earnings: Can it Surprise Wall Street?
Please enable JavaScript to continue using this application.